Linking diabetic cardiovascular disease with non-alcoholic fatty liver disease through L-carnitine: A hyperpolarized MRS study

Linking diabetic cardiovascular disease with non-alcoholic fatty liver disease through L-carnitine: A hyperpolarized MRS study

書誌詳細
主要な著者:	Savic, D, Ball, V, Pavlides, M, Heather, LC, Tyler, DJ
フォーマット:	Conference item
言語:	English
出版事項:	Elsevier 2019

類似資料

The importance of the fatty acid transporter L-carnitine in non-alcoholic fatty liver disease (NAFLD)
著者:: Savic, D, 等
出版事項: (2020)

L-Carnitine stimulates in vivo carbohydrate metabolism in the Type 1 diabetic heart as demonstrated by hyperpolarized MRI
著者:: Savic, D, 等
出版事項: (2021)

Simultaneous in vivo assessment of cardiac and hepatic metabolism in the diabetic rat using hyperpolarized MRS
著者:: Le Page, L, 等
出版事項: (2016)

Detection and alterations of acetylcarnitine (AC) in human liver by 1H MRS at 3T after supplementation with L-carnitine
著者:: Savic, D, 等
出版事項: (2022)

Non-alcoholic fatty liver disease
著者:: Pavlides, M, 等
出版事項: (2019)

Assessing the optimal preparation strategy to minimize the variability of cardiac pyruvate dehydrogenase flux measurements with hyperpolarized MRS
著者:: Timm, KN, 等
出版事項: (2018)

Role of Carnitine in Non-alcoholic Fatty Liver Disease and Other Related Diseases: An Update
著者:: Na Li, 等
出版事項: (2021-08-01)

Investigating the functional and metabolic role of carnitine in the diabetic heart using hyperpolarized MRI
著者:: Savic, D
出版事項: (2018)

L-Carnitine Stimulates In Vivo Carbohydrate Metabolism in the Type 1 Diabetic Heart as Demonstrated by Hyperpolarized MRI
著者:: Dragana Savic, 等
出版事項: (2021-03-01)

Clinical cardiovascular applications of hyperpolarized magnetic resonance
著者:: Lewis, AJM, 等
出版事項: (2020)

Fast Padé transform accelerated CSI for hyperpolarized MRS
著者:: Hansen, E, 等
出版事項: (2016)

Cardiovascular Applications of Hyperpolarized MRI.
著者:: Tyler, D
出版事項: (2011)

Non-Alcoholic Fatty Liver Disease and Cardiovascular Comorbidities: Pathophysiological Links, Diagnosis, and Therapeutic Management
著者:: Alexandra Jichitu, 等
出版事項: (2021-04-01)

Hyperpolarized 13 C and 31 P MRS detects differences in cardiac energetics, metabolism, and function in obesity, and responses following treatment
著者:: Lewis, AJM, 等
出版事項: (2024)

Non-Alcoholic Fatty Liver Disease, Atherosclerosis, and Cardiovascular Disease in Asia
著者:: Yohwan Lim, 等
出版事項: (2023-06-01)

The role of non-alcoholic fatty liver disease in the development of cardiovascular diseases
著者:: R. A Eganyan
出版事項: (2018-03-01)

In vivo carbon-13 dynamic MRS and MRSI of normal and fasted rat liver with hyperpolarized 13C-pyruvate.
著者:: Hu, S, 等
出版事項: (2009)

Cardiovascular Risk in Patients with Non-alcoholic Fatty Liver Disease
著者:: Hak Soo Kim, 等
出版事項: (2017-06-01)

Hyperpolarized magnetic resonance: a novel technique for the in vivo assessment of cardiovascular disease.
著者:: Schroeder, M, 等
出版事項: (2011)

Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism
著者:: Tae Hyun Kim, 等
出版事項: (2021-12-01)

The genetic interactions between non-alcoholic fatty liver disease and cardiovascular diseases
著者:: Nicholas W.S. Chew, 等
出版事項: (2022-08-01)

Association of non-alcoholic fatty liver disease with cardiovascular disease and subclinical atherosclerosis
著者:: Rahul Sao, 等
出版事項: (2017-07-01)

Management of Cardiovascular Risk in the Non‑alcoholic Fatty Liver Disease Setting
著者:: Paula Luque-Linero, 等
出版事項: (2024-05-01)

Cardiovascular Risk Induced by the Presence of Non-alcoholic Fatty Liver Disease
著者:: Daciana Dascalu
出版事項: (2023-04-01)

Non-alcoholic fatty liver disease and cardiovascular pathology: pathogenetic parallels
著者:: G. Yu. Knorring, 等
出版事項: (2024-08-01)

Non-alcoholic fatty liver disease and cardiovascular risks: A review
著者:: Yulia V. Kotovskaya
出版事項: (2023-07-01)

BIOMARKERS OF CARDIOVASCULAR RISK IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
著者:: Petrov I. M., 等
出版事項: (2020-06-01)

Genetics of Non-Alcoholic Fatty Liver and Cardiovascular Disease: Implications for Therapy?
著者:: Karthik Chandrasekharan, 等
出版事項: (2020-01-01)

Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease
著者:: Bilon Khambu, 等
出版事項: (2018-09-01)

Research Progress in the Correlation of Non-alcoholic Fatty Liver Disease and Metabolic-associated Fatty Liver Disease with Cardiovascular Diseases in China and Abroad
著者:: NI Xuetong, WANG Ruoxi, ZHANG Jing, YANG Xinghua
出版事項: (2024-06-01)

The Role of Carnitine Orotate Complex in Fatty Liver
著者:: Hyon-Seung Yi
出版事項: (2021-11-01)

Cardiovascular Diseases and Non-Alcoholic Fatty Liver Disease: Relationship and Pathogenetic Aspects of Pharmacotherapy
著者:: A. V. Nelidova, 等
出版事項: (2022-01-01)

Risk factors for cardiovascular disease in patients with non-alcoholic fatty liver disease with polymorbidity
著者:: E. V. Sevostyanova, 等
出版事項: (2019-11-01)

Determining Subclinical Cardiovascular and Cardiac Diseases in Patients with Non-Alcoholic Fatty Liver Disease
著者:: Beliz Bahar Karaoğlan, 等
出版事項: (2023-03-01)

Hyperpolarized butyrate: a metabolic probe of short chain fatty acid metabolism in the heart.
著者:: Ball, DR, 等
出版事項: (2014)

Cardiovascular involvement after liver transplantation: role of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
著者:: Rosa Lombardi, 等
出版事項: (2021-02-01)

Extracellular Vesicles in Non-alcoholic Fatty Liver Disease and Alcoholic Liver Disease
著者:: Dongqing Wu, 等
出版事項: (2021-07-01)

Clinical translation of hyperpolarized magnetic resonance for cardiovascular and metabolic diseases
著者:: Lewis, A
出版事項: (2017)

Models to predict non-alcoholic fatty liver disease linked to obesity in Morocco
著者:: Habiba Liba, 等
出版事項: (2022-09-01)

NON-ALCOHOLIC FATTY LIVER DISEASE AND CARDIOVASCULAR RISK: SCIENTIFIC PROBLEM STATE
著者:: O. M. Drapkina, 等
出版事項: (2017-11-01)